COVID-19 FDA Health Care Reform 
Kaiser Health News
MARCH 15, 2023
Las muertes por sobredosis de opioides han aumentado de manera constante en los Estados Unidos en las últimas dos décadas, con un pico al principio de la pandemia de covid-19. Los CDC dicen que el fentanilo ilícito ha alimentado un aumento reciente en las muertes por sobredosis.
Kaiser Health News
MARCH 15, 2023
Las muertes por sobredosis de opioides han aumentado de manera constante en los Estados Unidos en las últimas dos décadas, con un pico al principio de la pandemia de covid-19. Los CDC dicen que el fentanilo ilícito ha alimentado un aumento reciente en las muertes por sobredosis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
NOVEMBER 15, 2023
DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone.
Kaiser Health News
MARCH 15, 2023
in the past two decades, with a spike early in the covid-19 pandemic. The FDA approves new drugs and their reformulations, but the guidance it provides for how to start or wean patients could urge clinicians to do so with caution, Kertesz said. The 2022 revisions are “a dramatic change,” he said.
Kaiser Health News
MARCH 15, 2023
in the past two decades, with a spike early in the covid-19 pandemic. The FDA approves new drugs and their reformulations, but the guidance it provides for how to start or wean patients could urge clinicians to do so with caution, Kertesz said. The 2022 revisions are “a dramatic change,” he said.
Hall Render
MARCH 11, 2022
in supplemental COVID-19 aid. CMS Innovation Center Launches New Initiative To Advance Health Equity. COVID-19 funding is tapped out, HHS says. FDA final guidance presses industry to be ‘recall ready’ Final vaccine mandate deadlines still in play, despite removal vote. Congress’ $1.5
Hall Render
MAY 10, 2024
Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’
Expert insights. Personalized for you.
52 
Let's personalize your content